Please use this identifier to cite or link to this item:
|Title:||Consumption of nuts and seeds and pancreatic ductal adenocarcinoma risk in the European Prospective Investigation into cancer and Nutrition|
|Author:||Obón Santacana, Mireia|
Luján Barroso, Leila
Mancini, Francesca Romana
Rodríguez Barranco, Miguel
Wareham, Nicholas J.
Schmidt, Julie A.
Bueno de Mesquita, H. Bas
González, Calos A.
Duell, Eric J.
|Abstract:||Four epidemiologic studies have assessed the association between nut intake and pancreatic cancer risk with contradictory results. The present study aims to investigate the relation between nut intake (including seeds) and pancreatic ductal adenocarcinoma (PDAC) risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Cox proportional hazards models were used to estimate hazards ratio (HR) and 95% confidence intervals (95% CI) for nut intake and PDAC risk. Information on intake of nuts was obtained from the EPIC country‐specific dietary questionnaires. After a mean follow‐up of 14 years, 476,160 participants were eligible for the present study and included 1,283 PDAC cases. No association was observed between consumption of nuts and PDAC risk (highest intake vs nonconsumers: HR, 0.89; 95% CI, 0.72-1.10; p‐trend = 0.70). Furthermore, no evidence for effect‐measure modification was observed when different subgroups were analyzed. Overall, in EPIC, the highest intake of nuts was not statistically significantly associated with PDAC risk.|
|Note:||Versió postprint del document publicat a: https://doi.org/10.1002/ijc.32415|
|It is part of:||International Journal of Cancer, 2019, vol. 146, num. 15, p. 76-84|
|Appears in Collections:||Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil)|
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.